Business · 25/05/2023
FDA Clears Heparin Sodium Injection for Approval
The US Food and Drug Administration has determined that Heparin Sodium Injection 5000 USP Units per Milliliter was not withdrawn from sale due to safety or effectiveness concerns, paving the way for the approval of abbreviated new drug applications for this medication.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →